Literature DB >> 11496855

The coxibs, selective inhibitors of cyclooxygenase-2.

G A FitzGerald1, C Patrono.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496855     DOI: 10.1056/NEJM200108093450607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  284 in total

1.  Clinical practice guidelines for the care and treatment of breast cancer: the management of chronic pain in patients with breast cancer (summary of the 2001 update).

Authors:  C Emery; R Gallagher; M Hugi; M Levine
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

2.  Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction.

Authors:  Muredach Reilly; Garret A FitzGerald
Journal:  BMJ       Date:  2002-01-12

Review 3.  Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

Authors:  C Patrono; P Patrignani; L A García Rodríguez
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

4.  Cyclo-oxygenase-2 inhibition and exacerbation of myocardial dysfunction--protection with nitric oxide?

Authors:  Gordon Letts
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 5.  Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs.

Authors:  Mario Sánchez-Borges; Arnaldo Capriles-Hulett; Fernan Caballero-Fonseca
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

6.  Do cyclooxygenase inhibitors increase risk of cardiovascular thrombotic events?

Authors:  Brent Kvern
Journal:  Can Fam Physician       Date:  2002-09       Impact factor: 3.275

7.  All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal study.

Authors:  Stephen J Kerr; Debra S Rowett; Geoffrey P Sayer; Susan D Whicker; Deborah C Saltman; Andrea Mant
Journal:  Br J Clin Pharmacol       Date:  2010-05-06       Impact factor: 4.335

Review 8.  Cyclo-oxygenase-2-specific inhibitors and cardiovascular morbidity.

Authors:  Luis M Ruilope; Antonio Coca; José R Banegas; Jose Luis Pablos; Manuel Luque
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

9.  Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction.

Authors:  Raymond G Schlienger; Hershel Jick; Christoph R Meier
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

Review 10.  Clinical use and pharmacological properties of selective COX-2 inhibitors.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.